Human Longevity Stock
Human Longevity is on a mission to discover and harness the technological and biological unlocks that amplify span of life, health, and high-performance. HLI’s mission is to identify the therapeutically targetable mechanisms responsible for age-related human biological decline and to apply this intelligence to develop innovative solutions to interrupt or block those processes, meaningfully extending the human lifespan.
Sign up for SecondMarket™ to view the market and buy or sell Human Longevity Stock
Buy + SellHuman Longevity Funding
Sign up to gain insights into Human Longevity funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Aug 21, 2024 | Series B | 21.50M | ||
| Apr 25, 2023 | Series B | 10.50M | ||
| Jun 18, 2019 | Series A | 20.06M | ||
| Feb 16, 2017 | Series B | 203.33M | ||
| Mar 26, 2015 | Series B | 319.50M | ||
| Mar 20, 2014 | Series A | 80.00M |
See Human Longevity Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Human Longevity Stock Valuation + Share Prices
View real-time Tape D™ data on Human Longevity stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Human Longevity Management Team
President, Chief Innovation Officer
David Karow
Director
Brett Blundy
Director
Wei-Wu He
Co-Founder, Director
Peter Diamandis
Chief Privacy Officer
Mert Gambito
Director
Alan B. Colowick
Director
Robert Duggan
Director
Robert Hariri
Director
Maky Zanganeh
Director
KT Lim
Chief Medical Officer
Julie Chen
Co-Founder
J. Craig Venter
Human Longevity Major Investors
TVM Capital Healthcare
Panacea Venture
Faridan Ventures
Celgene Corp
Illumina
Emerging Technology Partners LLC
OS Fund
BB Retail Capital
Genting Berhad
GE Ventures (General Electric Company)
Draper Fisher Jurvetson
Learn More About Human Longevity Stock
Buy Human Longevity Stock
01Human Longevity stock does not trade on public stock exchanges. Human Longevity stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Human Longevity stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Human Longevity Stock
02Human Longevity Stock does not trade on public stock exchanges. In order to sell Human Longevity shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Human Longevity Stock Price
03Human Longevity does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Human Longevity share price and other valuable private market data.
Read more about secondary market private company stock prices:
Human Longevity Stock Ticker Symbol
04There is no ticker symbol for Human Longevity stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Human Longevity Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Human Longevity stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Human Longevity Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Human Longevity stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Human Longevity Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Human Longevity IPO
08Human Longevity is a private company and has not had an IPO. There is currently no Human Longevity IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Human Longevity IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Human Longevity Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
